El diagnóstico de animales de compañía es un aspecto fundamental de la medicina veterinaria que implica diversas pruebas y procedimientos utilizados para diagnosticar afecciones de salud en mascotas y otros animales de compañía. Desde exámenes físicos y análisis de sangre hasta exploraciones por imágenes y procedimientos más avanzados como biopsias y endoscopias , el diagnóstico de animales de compañía ayuda a los veterinarios a identificar la causa subyacente de los síntomas o enfermedades de una mascota para poder recomendar el tratamiento adecuado.
La creciente prevalencia de enfermedades zoonóticas e infecciosas ha hecho que el diagnóstico de animales de compañía sea esencial para el diagnóstico y tratamiento oportunos de dichas enfermedades. La creciente tasa de propietarios de mascotas en todo el mundo está impulsando la demanda de diagnósticos de animales de compañía, ya que los propietarios de mascotas son más conscientes de la importancia de los controles regulares y el cuidado preventivo para sus mascotas. El desarrollo de herramientas y tecnologías de diagnóstico avanzadas ha mejorado la precisión y la eficiencia de los diagnósticos de animales de compañía, lo que facilita a los veterinarios el diagnóstico y el tratamiento de una amplia gama de enfermedades.
La mayor prevalencia de enfermedades zoonóticas e infecciosas es uno de los principales impulsores de esta industria. El diagnóstico de animales de compañía se ha vuelto fundamental para la detección temprana y el tratamiento de enfermedades que pueden transmitirse de los animales a las personas. Con un mayor conocimiento de las enfermedades zoonóticas, los dueños de mascotas están más dispuestos a llevar a sus mascotas a controles regulares y pruebas de diagnóstico para salvaguardar la salud y la seguridad de sus mascotas.
The rising pet ownership rate in the world is another important factor driving the companion animal diagnostics industry. As owners become more aware of the need of routine checkups and preventative care for their dogs, there is a growing demand for companion animal diagnostics. The link between humans and animals has also become deeper through time, and pets are now frequently regarded as members of the family.
The high cost of diagnostic testing is one of the main obstacles. Some diagnostic procedures for companion animals can be prohibitively expensive for pet owners, which could reduce demand and delay the diagnosis of some conditions. This may be especially true for pet owners with little financial means or no pet insurance.
The increasing use of telemedicine in veterinary care is also an opportunity for the companion animal diagnostics market. Telemedicine allows pet owners to connect with veterinarians remotely, enabling them to receive diagnostic and treatment recommendations without leaving their homes. The use of telemedicine can expand the reach of veterinary care, especially in areas where access to veterinary clinics may be limited.
| ATTRIBUTE | DETAILS |
| Study period | 2022-2029 |
| Base year | 2022 |
| Estimated year | 2023 |
| Forecasted year | 2023-2029 |
| Historical period | 2018-2022 |
| Unit | Value (USD Billion) |
| Segmentation | By Technology, By Application, By Animal, By End-User, By Region |
| By Technology |
|
| By Application |
|
| By Animal |
|
| By End-User |
|
| By Region |
|
The global companion animal diagnostics market is expected to grow at 9.2 % CAGR from 2020 to 2029. It is expected to reach above 5.56 USD billion by 2029 from 2.76 USD billion in 2020.
North America dominates the companion animal diagnostics market, with a market share of over 46%.
IDEXX Laboratories, Inc., Zoetis Inc., Heska Corporation, Neogen Corporation, Thermo Fisher Scientific Inc., Virbac, Randox Laboratories Ltd., IDvet, Bio-Rad Laboratories, Inc., Agrolabo S.p.A., Abaxis, Inc., VCA, Inc., Fujifilm Holdings Corporation, Bionote, Inc., Eurolyser Diagnostica GmbH. are among the leading players in the global companion animal diagnostics market.
The global companion animal diagnostics market registered a CAGR of 9.2 % from 2020 to 2029.
The upcoming trends are an increase in the prevalence of zoonotic diseases in animals, rise in technological advancement in point-of-care diagnostics, and a rise in disposable income levels in developing regions.
The global companion animal diagnostics market is segmented by technology, application, animal, end-user and region.
Based on technology, the companion animal diagnostics market is segmented into immunodiagnostics, clinical biochemistry, hematology, urinalysis, molecular diagnostics, other companion animal diagnostics technologies. Immunodiagnostics involve the use of antibodies to detect specific antigens or proteins in a sample. This technology is commonly used for infectious disease testing, such as for heartworm, Lyme disease, and feline leukemia. It is used to diagnose infectious and chronic diseases like autoimmune disorders, cancers, and others. It is used in autoimmune disorders, infectious diseases, cardiovascular diseases, oncology, endocrinology, and others.
The clinical biochemistry category had the greatest revenue share in 2021. Blood haematological and biochemical markers are used to diagnose disease in unmanaged animals, whether they are wild or captive. The clinical examination of livestock and wild animals is done using serum biochemistry, and the state of the animal is determined by using haematological parameters. Clinical biochemistry involves the measurement of various biochemical parameters in blood or other bodily fluids.
Based on application, the companion animal diagnostics market is segregated into clinical pathology, bacteriology, virology, parasitology, other application. Due largely to the rise in the number of pathology tests done on pets, clinical pathology held the top position in the market in 2021. The field of clinical pathology encompasses cytopathology, haematology, clinical chemistry, immunohematology, urinalysis, coagulation, endocrinology, and general pathology. The need for unique diagnostic gadgets has risen as a result of pet owners' growing concern for the health of their animals. Bacteriology is involved with developing improved diagnostic methods for a wide variety of bacterial diseases and infections. Bacteriology is the examination of aerobic and anaerobic cultures, as well as the detection of bacterial infections in blood or serum samples.
Based on animal, the companion animal diagnostics market is classified into dog, cat, horse, other companion animals. Dog companion animal diagnostics dominates the market. The huge share and rapid expansion in this market sector are attributable to elements like rising dog ownership and population, rising zoonotic illness prevalence, and rising acceptance of canine pet insurgency in the US.
Dogs and cats are the most commonly tested companion animals in the market, and this segment is expected to continue to dominate the market in the coming years. Dogs and cats are often considered as family members and the demand for high-quality veterinary care is increasing. The growing awareness about preventive care and the increasing prevalence of chronic diseases among dogs and cats are driving the demand for diagnostic tests in this segment.
Based on end-user, the companion animal diagnostics market is bifurcated into diagnostics laboratories, veterinary clinics and hospitals, research institute and universities, home-care settings. The veterinary clinics and hospitals segment is expected to dominate the companion animal diagnostics market. Veterinary clinics and hospitals are the primary providers of veterinary care for companion animals. These facilities perform a wide range of services, including diagnostic testing, surgery, and medical treatment. Veterinary clinics and hospitals have on-site diagnostic equipment and expertise to perform a variety of diagnostic tests, including blood tests, X-rays, and ultrasounds.
[caption id="attachment_28960" align="aligncenter" width="1920"]
The companion animal diagnostics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
North America emerged as the market leader with a 46 % revenue share in the worldwide companion animal diagnostics market in 2021. Due to its high disposable incomes and quick economic growth, North America dominates the companion animal diagnostics industry. Additionally, the existence of major players, established healthcare infrastructures, and an increase in veterinary healthcare expenditure are promoting market growth in this region over the course of the forecast period. Also, the presence of healthcare programmers and the rise in the number of initiatives to promote animal health during the forecast period fuel market expansion in this region.
The Asia Pacific region is anticipated to have the highest CAGR throughout the predicted period due to the rapid expansion of manufacturing facilities in developing nations like China and India. Over the anticipated period, rising R&D spending by top market players in the development of novel value-added products is anticipated to drive companion animal diagnostics growth in the sector.
[caption id="attachment_28966" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.